Lemma Tamiru Mamo, Bala Elias Teferi, Hordofa Mulatu Ayana, Solbana Lencho Kajela
Dukem Health Center Oromia Health Bureau Addis Ababa Ethiopia.
Department of Public Health Ambo University Ambo Ethiopia.
Health Sci Rep. 2024 Mar 12;7(3):e1972. doi: 10.1002/hsr2.1972. eCollection 2024 Mar.
Cervical cancer is a global public health problem and the second most common cancer which leads to morbidity and mortality among women in developing countries like Ethiopia. In Ethiopia, annually 6294 new cervical cancer cases and 4884 deaths are estimated in 2018 alone. This study aimed to assess the prevalence and associated factors of precancerous cervical lesions among women on antiretroviral therapy (ART) at Dukem Health Center, Central Ethiopia.
An institution-based cross-sectional study was carried out among randomly selected 257 women receiving ART at Dukem Health Center. Data were collected using a pretested structured questionnaire, medical record review, and visual inspection with acetic acid. Collected data were entered into Epi-info 7.4 and exported to SPSS version 26 for analysis. The prevalence of precancerous cervical lesions and the characteristics of study participants were identified. Utilizing both binary and multivariable logistic regression models, the existence and degree of association with precancerous cervical lesions were determined with a value < 0.05 and a 95% confidence interval.
The prevalence of precancerous cervical lesions was 16% (95% CI: 11.7-20.6). Significant association was found between precancerous cervical lesions and a history of STIs (AOR = 4.30, 95% CI: 1.48-12.49), oral contraceptive use (AOR = 6.56, 95% CI: 2.10-20.50), having multiple lifetime sexual partners (AOR = 2.53: 95% CI: 1.05-6.10), and a recent CD4 count of less than 200 cells/mm (AOR: 11.33, 95% CI: 2.88-24.58).
In the study area, the prevalence of precancerous cervical lesions was relatively high. Therefore, concerned bodies are recommended to increase awareness of the prevention of sexually transmitted diseases and limit sexual partners.
宫颈癌是一个全球性的公共卫生问题,是发展中国家(如埃塞俄比亚)女性中导致发病和死亡的第二大常见癌症。在埃塞俄比亚,仅2018年估计每年就有6294例新发宫颈癌病例和4884例死亡。本研究旨在评估埃塞俄比亚中部杜凯姆健康中心接受抗逆转录病毒治疗(ART)的女性中宫颈癌前病变的患病率及相关因素。
在杜凯姆健康中心对随机选取的257名接受ART的女性进行了一项基于机构的横断面研究。通过预先测试的结构化问卷、病历审查和醋酸目视检查收集数据。收集的数据录入Epi-info 7.4并导出到SPSS 26版进行分析。确定宫颈癌前病变的患病率和研究参与者的特征。利用二元和多变量逻辑回归模型,以P值<0.05和95%置信区间确定与宫颈癌前病变的关联存在情况和程度。
宫颈癌前病变的患病率为16%(95%CI:11.7 - 20.6)。发现宫颈癌前病变与性传播感染史(调整后比值比[AOR]=4.30,95%CI:1.48 - 12.49)、口服避孕药使用(AOR = 6.56,95%CI:2.10 - 20.50)、有多个性伴侣(AOR = 2.53:95%CI:1.05 - 6.10)以及最近CD4细胞计数低于200个/mm³(AOR:11.33,95%CI:2.88 - 24.58)之间存在显著关联。
在研究区域,宫颈癌前病变的患病率相对较高。因此,建议相关机构提高对性传播疾病预防的认识并限制性伴侣数量。